DK0879054T3 - Anvendelse af pyrrolidionderivater til fremstilling af medikamenter til behandling af narkotikamisbrug - Google Patents

Anvendelse af pyrrolidionderivater til fremstilling af medikamenter til behandling af narkotikamisbrug

Info

Publication number
DK0879054T3
DK0879054T3 DK97904476T DK97904476T DK0879054T3 DK 0879054 T3 DK0879054 T3 DK 0879054T3 DK 97904476 T DK97904476 T DK 97904476T DK 97904476 T DK97904476 T DK 97904476T DK 0879054 T3 DK0879054 T3 DK 0879054T3
Authority
DK
Denmark
Prior art keywords
pyrrolidione
drugs
derivatives
manufacture
treatment
Prior art date
Application number
DK97904476T
Other languages
English (en)
Inventor
Andrees Bohme
Claude Guyon
Franco Manfre
Marie-Christine Dubroeucq
Walter Fratta
Assunta Imperato
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0879054T3 publication Critical patent/DK0879054T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97904476T 1996-02-07 1997-02-03 Anvendelse af pyrrolidionderivater til fremstilling af medikamenter til behandling af narkotikamisbrug DK0879054T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9601481A FR2744361B1 (fr) 1996-02-07 1996-02-07 Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
PCT/FR1997/000209 WO1997028798A1 (fr) 1996-02-07 1997-02-03 Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues

Publications (1)

Publication Number Publication Date
DK0879054T3 true DK0879054T3 (da) 2008-04-07

Family

ID=9488931

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97904476T DK0879054T3 (da) 1996-02-07 1997-02-03 Anvendelse af pyrrolidionderivater til fremstilling af medikamenter til behandling af narkotikamisbrug

Country Status (13)

Country Link
US (1) US6150387A (da)
EP (1) EP0879054B1 (da)
JP (1) JP2000504681A (da)
AR (1) AR013559A1 (da)
AU (1) AU1727297A (da)
DE (1) DE69738320T2 (da)
DK (1) DK0879054T3 (da)
ES (1) ES2297850T3 (da)
FR (1) FR2744361B1 (da)
PT (1) PT879054E (da)
TW (1) TW514528B (da)
WO (1) WO1997028798A1 (da)
ZA (1) ZA97872B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002072582A1 (en) 2001-03-12 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Methods for the synthesis of densely functionalized pyrrolidine template libraries
US6697016B1 (en) * 2002-09-30 2004-02-24 Motorola, Inc. Self adjustment of a frequency offset in a GPS receiver
US7405210B2 (en) * 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
ATE483708T1 (de) 2004-03-08 2010-10-15 Prosidion Ltd Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase
ATE424821T1 (de) 2004-12-02 2009-03-15 Prosidion Ltd Pyrrolopyridin-2-karbonsäureamide
US8247438B2 (en) 2008-02-27 2012-08-21 Neuropill, Inc. Methods for treating schizophrenia
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
KR20220008824A (ko) 2019-04-17 2022-01-21 컴퍼스 패쓰파인더 리미티드 실로시빈으로 불안 장애, 두통 장애 및 섭식 장애를 치료하는 방법
IL312785B2 (en) 2020-05-19 2026-06-01 Cybin Irl Ltd Deuterated tryptamine derivatives and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678938B1 (fr) * 1991-07-10 1993-10-08 Rhone Poulenc Rorer Sa Derives de pyrrolidine, leur preparation et les medicaments les contenant.
EP0617621A4 (en) * 1991-12-20 1995-04-05 Merck Sharp & Dohme CENTRAL CHOLECYSTOKININE ANTAGONISTS WITH PHARMACEUTICAL EFFECTIVENESS.
FR2700168B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Dérivés de thiazolidine, leur préparation et les médicaments les contenant.
FR2700165B1 (fr) * 1993-01-07 1995-02-17 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
FR2700167B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine et thiazolidine, leur préparation et les médicaments les contenant.
FR2734724B1 (fr) * 1995-06-01 1997-07-04 Rhone Poulenc Rorer Sa Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'alcoolisme

Also Published As

Publication number Publication date
DE69738320D1 (de) 2008-01-10
US6150387A (en) 2000-11-21
DE69738320T2 (de) 2008-10-09
ZA97872B (en) 1997-08-04
ES2297850T3 (es) 2008-05-01
TW514528B (en) 2002-12-21
JP2000504681A (ja) 2000-04-18
AU1727297A (en) 1997-08-28
WO1997028798A1 (fr) 1997-08-14
FR2744361B1 (fr) 1998-02-27
EP0879054B1 (fr) 2007-11-28
FR2744361A1 (fr) 1997-08-08
PT879054E (pt) 2008-03-05
EP0879054A1 (fr) 1998-11-25
AR013559A1 (es) 2001-01-10

Similar Documents

Publication Publication Date Title
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
DK0797991T3 (da) Lægemiddelformulering med forhalet frigivelse
DE69935681D1 (de) Vorrichtungen zur Medikamentverabreichung
BR9700829A (pt) Uso de interferon consensus humano para a produção de um medicamento
MA26549A1 (fr) Medicaments
NO20006630L (no) Farmasöytisk sammensetning for behandlingen av diabetes
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
IS5245A (is) Lyfjablanda úr ómeprasól
EE03904B1 (et) Graanul, farmatseutiline doseerimisvorm, graanulite valmistamismeetod ja ravimiga kaetud graanulid
ATE187063T1 (de) Arzneimittel
DE69737936D1 (de) Arzneimittel
NO20001219D0 (no) Blanding for medikament-administrasjon
NO983832D0 (no) Medikamentinhalator med pulver
NO971811D0 (no) Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler
DK0979079T3 (da) Anvendelse af tetrahydropyridinderivater til fremstilling af lægemidler til behandling af sygdomme, der medförer en demyelinisering
NO20005179D0 (no) Medikament behandling
BR9708528A (pt) Terapia com libertação uniforme de droga
NO20001375L (no) Legemiddelformulering med kontrollert virkestoffrigivning
NO20003229D0 (no) Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske legemidler for behandling av proliferaktive sykdommer
DK1150681T3 (da) Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
EE9800209A (et) Antiglükokortikoidne ravimaine
FI973185L (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
DE69832974D1 (de) Gerät zur intrakardialen verabreichung von medikamenten
NO20012226L (no) Terapeutiske midler for medikamentavhengighet